| CYSB2200289 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-12-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CXSS2200007 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CYSB2400166 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2400282 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-10-26 | | Gan & Lee Pharmaceuticals | | | view |
| JYSZ2100524 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2021-07-21 | | | | | view |
| CYSB2300084 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2023-04-19 | | Gan & Lee Pharmaceuticals | | | view |
| JXSB2200031 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-03-17 | | Novo Nordisk A/S | | | view |
| JXSB2200030 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-03-17 | | Novo Nordisk A/S | | | view |
| CYSB2400053 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-02-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2200124 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-05-31 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2400365 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2024-06-04 | | Ningbo Kunpeng BIOTECH Co Ltd | | | view |
| CYSB2101104 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-06-25 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2101305 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-12-23 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2400219 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-17 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSS2101010 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.4) | New Drug Application | 2021-07-13 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL2300177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-03-08 | | Nanjing Han Xin Pharmaceutical Technology Co Ltd | | | view |
| CYSB2101163 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-08-20 | | Gan & Lee Pharmaceuticals | | | view |
| JYSB2200002 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk A/S | | | view |
| CXSL2400058 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2024-01-25 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CXSS2200009 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-28 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
